L’hôpital Antoine-Béclère est un centre hospitalier universitaire public du GHU Assistance publique - Hôpitaux de Paris - Université Paris-Saclay, situé à Clamart dans les Hauts-de-Seine, en France.

During the past decade, Hôpital Antoine-Béclère conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 15 clinical trials were completed, i.e. on average, 22.4% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 10 clinical trials were completed. i.e. 43.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Antoine-Béclère" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 33 trials, followed by "The Lymphoma Academic Research Organisation" with 8 trials sponsored, "ANRS, Emerging Infectious Diseases" with 6 trials sponsored, "Actelion" with 5 trials sponsored and "Centre Hospitalier Universitaire de Nīmes" with 5 trials sponsored. Other sponsors include 87 different institutions and companies that sponsored additional 74 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Antoine-Béclère" #1 collaborator was "Institut National de la Santé Et de la Recherche Médicale, France" with 7 trials as a collaborator, "Hopital Antoine Beclere" with 6 trials as a collaborator, "Ministry of Health, France" with 4 trials as a collaborator, "National Cancer Institute, France" with 4 trials as a collaborator and "Assistance Publique - Hôpitaux de Paris" with 3 trials as a collaborator. Other collaborators include 139 different institutions and companies that were collaborators in the rest 128 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Antoine-Béclère" are "Pulmonary Hypertension" (6 trials), "Breast Cancer" (5 trials), "Colorectal Cancer" (5 trials), "Multiple Myeloma" (5 trials) and "Pulmonary Arterial Hypertension" (5 trials). Many other conditions were trialed in "Hôpital Antoine-Béclère" in a lesser frequency.

Most popular intervention types in "Hôpital Antoine-Béclère" are "Drug" (66 trials), "Procedure" (29 trials), "Other" (23 trials), "Device" (18 trials) and "Biological" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Bosentan" (3 trials), "Dacarbazine" (3 trials), "Lenalidomide" (3 trials) and "Vinblastine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Antoine-Béclère" are 102 trials for "All" genders, 46 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hôpital Antoine-Béclère". 2 are not yet recruiting, 16 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 87 completed trials in Hôpital Antoine-Béclère, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Antoine-Béclère, 1 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 41 trials that are defined as “Not Applicable".